Piyush Goyal meets Swiss State Secretary to boost pharma investments

Written By :  MD Bureau
Published On 2025-11-27 10:45 GMT   |   Update On 2025-11-27 10:51 GMT
Advertisement

New Delhi: Union Commerce Minister Piyush Goyal on Thursday held a meeting with Helene Budliger Artieda, Switzerland’s State Secretary for Economic Affairs, to explore investment opportunities in the pharmaceutical sector.

Artieda is currently visiting India with a pharma delegation of Switzerland.

“Co-chaired a meeting with SECO_StateSec Helene Budliger Artieda with Swiss pharma and biotech companies. Discussions focused on avenues of further cooperation in R&D and expanding investment opportunities for Swiss pharma companies to leverage India's robust healthcare sector,” Goyal shared in a post on X.

Advertisement

As per IANS, he added, “Also, discussed the progress made under the India-EFTA Trade and Economic Partnership Agreement (TEPA) with an aim to further enhance collaboration across key sectors for mutual growth.” 

In a post on X, Artieda also shared holding a “constructive exchange with Secretary of Finance Anuradha Thakur on accelerating negotiations towards a Bilateral Investment Treaty”.

“A crucial agreement for our investors!” Artieda said.

Welcoming Artieda, Ambassador of Switzerland to India, Maya Tissafi shared that the Swiss Secretary’s meeting with Goyal aims to strengthen “the regulatory framework and deepening cooperation”. These are key for new investments and to set TEPA fully in motion,” she added on X.

India has been working on TEPA with EFTA countries comprising Switzerland, Iceland, Norway, and Liechtenstein. The India-EFTA TEPA came into effect on October 1.

The agreement was signed on the 10th of March last year in New Delhi. EFTA is an important regional group with several growing opportunities for enhancing international trade in goods and services.

The agreement focuses on market access related to goods, trade facilitation, investment promotion, market access to services, intellectual property rights, trade, and sustainable development.

Under it, EFTA’s market access covers 100 percent of non-agricultural products and tariff concessions on Processed Agricultural Products. The agreement also offers a binding commitment of 100 billion US dollars in investment in India in the next 15 years. It will also facilitate the generation of one million direct jobs through such investment.

The TEPA will empower India’s exporters by providing access to specialised inputs and creating a conducive trade and investment environment. This would boost exports of Indian made goods as well as provide opportunities for the services sector to access more markets.

According to the Ministry of Commerce and Industry, a dedicated EFTA Desk has also been operational since February this year, which is a single-window mechanism for investment facilitation to support EFTA businesses in investing, expanding, and establishing operations in India.

Read also: ICMR, CDSCO, Industry leaders emphasize collaboration, regulatory reforms to strengthen India's pharma leadership

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News